Using Machine Learning to Evaluate the Value of Genetic Liabilities in the Classification of Hypertension within the

Gideon MacCarthy1, Raha Pazoki1,2

  • 1Cardiovascular and Metabolic Research Group, Division of Biomedical Sciences, Department of Life Sciences, College of Health, Medicine and Life Sciences, Brunel University London, London UB8 3PH, UK.

PubMed

Insights

This study found that including genetic liabilities for cholesterol and LDL improved hypertension prediction models. Machine learning models incorporating genetic data offer valuable insights for hypertension classification.

Area of Science:

  • Cardiovascular disease research
  • Genetics and personalized medicine
  • Machine learning in healthcare

Background:

  • Hypertension is a major risk factor for cardiovascular diseases (CVD), contributing significantly to global mortality.
  • Existing hypertension prediction models often lack genetic liability assessment.
  • This study explores the impact of genetic risk factors on hypertension prediction.

Purpose of the Study:

  • To develop an effective hypertension classification model using machine learning.
  • To investigate the influence of genetic liability for CVD risk factors on hypertension risk.
  • To compare random forest and neural network models for hypertension prediction.

Main Methods:

  • Utilized genetic variants from GWAS to construct genetic liabilities for CVD risk factors.
  • Applied random forest and neural network models to a dataset of 244,718 European participants.
  • Evaluated models using AUC, calibration, and net reclassification improvement.

Main Results:

  • Models without genetic liabilities achieved AUCs of 0.70 (random forest) and 0.72 (neural network).
  • Adding genetic liabilities improved AUC for random forest but not neural network.
  • The best model (random forest) achieved an AUC of 0.71, incorporating genetic liabilities for total cholesterol and LDL.

Conclusions:

  • Incorporating genetic liabilities for lipids can enhance machine learning models for hypertension classification.
  • Genetic data provides incremental value beyond baseline characteristics in predicting hypertension.
  • This approach holds promise for personalized risk assessment in cardiovascular health.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
559
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
65.7K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
705
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
559
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K